MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Todays Market
- Indian Stock Market Updates June 19, 2019
STRIDES PHARMA SCIENCE Plunges by 5%; BSE HEALTHCARE Index Down 1.4%
Wed, 19 Jun 02:38 PM
STRIDES PHARMA SCIENCE share price has plunged 5% and is presently trading at Rs 416.
Meanwhile, the BSE HEALTHCARE Index is at 12,729 (down 1.4%).
Among the top losers in the BSE HEALTHCARE Index today are STRIDES PHARMA SCIENCE (down 5.1%) and PIRAMAL ENTERPRISES (down 5.2%).
BIOCON (up 2.3%) and CAPLIN POINT (up 2.3%) are among the top gainers today.
Over the last one year, STRIDES PHARMA SCIENCE has moved up from Rs 405 to Rs 416, registering a gain of Rs 11 (up 2.8%)..
The BSE HEALTHCARE has moved down from 14,312 to 12,729, loss of 1,583 points (down 11.1%) during the last 12 months.
The top gainers among the BSE HEALTHCARE Index stocks during this same period were MERCK (up 62.3%), DIVIS LABORATORIES (up 40.4%) and IPCA LABS (up 34.4%).
FREE Subscription: Join Our YouTube Channel Today
What About the Benchmark Indices?
The BSE Sensex is at 39,436 (down 0.1%). The top gainers among the BSE Sensex stocks today are TATA STEEL (up 2.8%). The most traded stocks in the BSE Sensex are TATA STEEL and ITC.
In the meantime, NSE Nifty is at 11,802 (down 0.3%). TATA STEEL (up 2.8%) and ZEE ENTERTAINMENT (up 2.3%) are among the top gainers in NSE Nifty.
Over the last 12 months, the BSE Sensex has moved up from 35,548 to 39,436, registering a gain of 3,888 points (up 9.8%).
STRIDES PHARMA SCIENCE Financial Update...
STRIDES PHARMA SCIENCE net profit stood at Rs 650 million for the quarter ended March 2019, compared to a profit of Rs 316 million a year ago. Net Sales rose 5.7% to Rs 8.4 billion during the period as against Rs 7.9 billion in January-March 2018.
For the year ended March 2018, STRIDES PHARMA SCIENCE reported 58.6% decrease in net profit to Rs 1.3 billion compared to net profit of Rs 3.2 billion during FY17.
Revenue of the company grew 3.0% to Rs 28 billion during FY18.
The current Price to earnings ratio of STRIDES PHARMA SCIENCE, based on rolling 12 month earnings, stands at 33.4x.
Indian Share Market Update: Top Gainers and Losers
What else is happening in the markets today? Dig in...
- TRACK NOW:
- Most Active Stocks Rs 0 to 10
- Most Active Stocks Rs 10 to 20
- Top Gainers Today BSE A Group
- Top Gainers Today NSE Above Rs 20
- Top Gainers Today BSE Above Rs 20
- Top Gainers Today BSE Sensex
- Top Gainers Today BSE Small Cap
- Top Gainers Today BSE 500
- Top Losers Today BSE A Group
- Most Active Stocks Rs 1 to 2
- Top Losers Today NSE Above Rs 20
- Buzzing Stocks Today
- Most Popular Stocks BSE 30
- TRENDING ON EQUITYMASTER:
- Warren Buffett - The Value Investor
- Your Ultimate Guide to Penny Stock Investing
- How to Invest in Gold
- Basics of Value Investing
- Benjamin Graham
- The Best Bluechip Stocks to Buy
- How to Invest in Silver
- The Best Small-cap Stocks to Buy
- 10 Rules for Successful Long-Term Investing
- How to Invest in the Share Market
- Best Stocks to Buy Today
- How to Use P/E for Successful Investing
- How to Find Undervalued Stocks
- Differences Between Trading and Investing
- SWOT Analysis for Stocks
- The Best Dividend Stocks to Buy
Stock Market Updates
TV18 BROADCAST Share Price Up by 13%; BSE 500 Index Up 1.4% (Today's Market)
Mar 1, 2021 02:52 PMTV18 BROADCAST share price is trading up by 13% and its current market price is Rs 33. The BSE 500 is up by 1.4%. The top gainers in the BSE 500 Index are TV18 BROADCAST (up 12.7%) and JUST DIAL (up 13.1%). The top losers are SHILPA MEDICARE and SOBHA .
RITES Share Price Up by 7%; BSE CAPITAL GOODS Index Up 1.5% (Today's Market)
Mar 1, 2021 02:52 PMRITES share price is trading up by 7% and its current market price is Rs 263. The BSE CAPITAL GOODS is up by 1.5%. The top gainers in the BSE CAPITAL GOODS Index are RITES (up 6.7%) and GRINDWELL NORTON (up 5.8%). The top losers are SADBHAV ENGINEERING (down 0.1%) and HINDUSTAN AERO. (down 0.2%).
MRPL Share Price Up by 9%; BSE OIL & GAS Index Up 1.9% (Today's Market)
Mar 1, 2021 02:52 PMMRPL share price is trading up by 9% and its current market price is Rs 45. The BSE OIL & GAS is up by 1.9%. The top gainers in the BSE OIL & GAS Index are MRPL (up 9.3%) and CASTROL INDIA (up 5.1%). The top losers is PETRONET LNG (down 1.8%).
ITD CEMENTATION INDIA Share Price Up by 5%; BSE REALTY Index Up 1.5% (Today's Market)
Mar 1, 2021 02:52 PMITD CEMENTATION INDIA share price is trading up by 5% and its current market price is Rs 82. The BSE REALTY is up by 1.5%. The top gainers in the BSE REALTY Index are ITD CEMENTATION INDIA (up 5.2%) and MAHINDRA LIFESPACE (up 6.2%). The top losers is SOBHA .
SJVN Share Price Up by 5%; BSE POWER Index Up 2.1% (Today's Market)
Mar 1, 2021 02:52 PMSJVN share price is trading up by 5% and its current market price is Rs 27. The BSE POWER is up by 2.1%. The top gainers in the BSE POWER Index are SJVN (up 5.5%) and POWER GRID (up 5.6%). The top losers is GMR INFRA (down 0.2%).
Sensex Trades Over 300 Points Higher; Dow Futures Up by 204 Points (Today's Market)
Mar 1, 2021 12:30 pmShare markets in India are presently trading on a strong note. The BSE Sensex is trading up by 378 points, up 0.7% at 49,478 levels.
View More Indian Share Market NewsMost Popular
It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)
Feb 24, 2021Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.
Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)
Feb 16, 2021A look at what India's top equity mutual funds bought and sold in January 2021.
I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)
Feb 16, 2021Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.
Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)
Feb 25, 2021In this video, I'll show you how to get started on the path to daily trading profits.
MoreOUR TOP 5 IDEAS
- Free Report: Multibagger Stock Ideas 2021
- Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
- Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
- Free Report: The Secret to Increasing Your Trading Profits Daily!
- No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.
S&P BSE SENSEX
Mar 1, 2021 03:00 PM
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
- Basics of Value Investing
- Benjamin Graham
- How to Invest in Gold
- How to Invest in Silver
- Best Stocks to Buy Today
- Warren Buffett - The Value Investor
- The Best Small-cap Stocks to Buy
- The Best Bluechip Stocks to Buy
- Your Ultimate Guide to Penny Stock Investing
- 10 Rules for Successful Long-Term Investing
- How to Invest in the Share Market
- Momentum Moves
FOLLOW
APP
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster requests your view! Post a comment on "STRIDES PHARMA SCIENCE Plunges by 5%; BSE HEALTHCARE Index Down 1.4%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!